NextCure Inc (NXTC)
1.56
-0.02
(-1.27%)
USD |
NASDAQ |
May 31, 16:00
1.545
-0.02
(-0.96%)
After-Hours: 20:00
NextCure Cash from Financing (Quarterly): 0.001M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.001M |
| December 31, 2023 | 0.071M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.083M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.061M |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.079M |
| March 31, 2022 | 0.06M |
| December 31, 2021 | 0.123M |
| September 30, 2021 | -2.63M |
| June 30, 2021 | -0.404M |
| March 31, 2021 | -0.354M |
| Date | Value |
|---|---|
| December 31, 2020 | -0.398M |
| September 30, 2020 | -0.363M |
| June 30, 2020 | -0.414M |
| March 31, 2020 | -0.24M |
| December 31, 2019 | 161.31M |
| September 30, 2019 | -0.112M |
| June 30, 2019 | 78.88M |
| March 31, 2019 | 2.97M |
| December 31, 2018 | 90.73M |
| September 30, 2018 | -0.114M |
| June 30, 2018 | 30.90M |
| March 31, 2018 | -0.10M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.63M
Minimum
Sep 2021
161.31M
Maximum
Dec 2019
11.79M
Average
--
Median
Sep 2022
Cash from Financing (Quarterly) Benchmarks
| Assertio Holdings Inc | -0.206M |
| DiaMedica Therapeutics Inc | -0.001M |
| Terns Pharmaceuticals Inc | 0.00 |
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -12.61M |
| Cash from Investing (Quarterly) | 17.88M |
| Free Cash Flow | -51.41M |
| Free Cash Flow Per Share (Quarterly) | -0.4531 |
| Free Cash Flow Yield | -118.3% |